Identification and transcriptomic assessment of latent profile pediatric septic shock phenotypes.
Endotype
Phenotype
Precision medicine
Sepsis
Journal
Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902
Informations de publication
Date de publication:
17 Jul 2024
17 Jul 2024
Historique:
received:
10
03
2024
accepted:
05
07
2024
medline:
17
7
2024
pubmed:
17
7
2024
entrez:
16
7
2024
Statut:
epublish
Résumé
Sepsis poses a grave threat, especially among children, but treatments are limited owing to heterogeneity among patients. We sought to test the clinical and biological relevance of pediatric septic shock subclasses identified using reproducible approaches. We performed latent profile analyses using clinical, laboratory, and biomarker data from a prospective multi-center pediatric septic shock observational cohort to derive phenotypes and trained a support vector machine model to assign phenotypes in an internal validation set. We established the clinical relevance of phenotypes and tested for their interaction with common sepsis treatments on patient outcomes. We conducted transcriptomic analyses to delineate phenotype-specific biology and inferred underlying cell subpopulations. Finally, we compared whether latent profile phenotypes overlapped with established gene-expression endotypes and compared survival among patients based on an integrated subclassification scheme. Among 1071 pediatric septic shock patients requiring vasoactive support on day 1 included, we identified two phenotypes which we designated as Phenotype 1 (19.5%) and Phenotype 2 (80.5%). Membership in Phenotype 1 was associated with ~ fourfold adjusted odds of complicated course relative to Phenotype 2. Patients belonging to Phenotype 1 were characterized by relatively higher Angiopoietin-2/Tie-2 ratio, Angiopoietin-2, soluble thrombomodulin (sTM), interleukin 8 (IL-8), and intercellular adhesion molecule 1 (ICAM-1) and lower Tie-2 and Angiopoietin-1 concentrations compared to Phenotype 2. We did not identify significant interactions between phenotypes, common treatments, and clinical outcomes. Transcriptomic analysis revealed overexpression of genes implicated in the innate immune response and driven primarily by developing neutrophils among patients designated as Phenotype 1. There was no statistically significant overlap between established gene-expression endotypes, reflective of the host adaptive response, and the newly derived phenotypes, reflective of the host innate response including microvascular endothelial dysfunction. However, an integrated subclassification scheme demonstrated varying survival probabilities when comparing patient endophenotypes. Our research underscores the reproducibility of latent profile analyses to identify pediatric septic shock phenotypes with high prognostic relevance. Pending validation, an integrated subclassification scheme, reflective of the different facets of the host response, holds promise to inform targeted intervention among those critically ill.
Sections du résumé
BACKGROUND
BACKGROUND
Sepsis poses a grave threat, especially among children, but treatments are limited owing to heterogeneity among patients. We sought to test the clinical and biological relevance of pediatric septic shock subclasses identified using reproducible approaches.
METHODS
METHODS
We performed latent profile analyses using clinical, laboratory, and biomarker data from a prospective multi-center pediatric septic shock observational cohort to derive phenotypes and trained a support vector machine model to assign phenotypes in an internal validation set. We established the clinical relevance of phenotypes and tested for their interaction with common sepsis treatments on patient outcomes. We conducted transcriptomic analyses to delineate phenotype-specific biology and inferred underlying cell subpopulations. Finally, we compared whether latent profile phenotypes overlapped with established gene-expression endotypes and compared survival among patients based on an integrated subclassification scheme.
RESULTS
RESULTS
Among 1071 pediatric septic shock patients requiring vasoactive support on day 1 included, we identified two phenotypes which we designated as Phenotype 1 (19.5%) and Phenotype 2 (80.5%). Membership in Phenotype 1 was associated with ~ fourfold adjusted odds of complicated course relative to Phenotype 2. Patients belonging to Phenotype 1 were characterized by relatively higher Angiopoietin-2/Tie-2 ratio, Angiopoietin-2, soluble thrombomodulin (sTM), interleukin 8 (IL-8), and intercellular adhesion molecule 1 (ICAM-1) and lower Tie-2 and Angiopoietin-1 concentrations compared to Phenotype 2. We did not identify significant interactions between phenotypes, common treatments, and clinical outcomes. Transcriptomic analysis revealed overexpression of genes implicated in the innate immune response and driven primarily by developing neutrophils among patients designated as Phenotype 1. There was no statistically significant overlap between established gene-expression endotypes, reflective of the host adaptive response, and the newly derived phenotypes, reflective of the host innate response including microvascular endothelial dysfunction. However, an integrated subclassification scheme demonstrated varying survival probabilities when comparing patient endophenotypes.
CONCLUSIONS
CONCLUSIONS
Our research underscores the reproducibility of latent profile analyses to identify pediatric septic shock phenotypes with high prognostic relevance. Pending validation, an integrated subclassification scheme, reflective of the different facets of the host response, holds promise to inform targeted intervention among those critically ill.
Identifiants
pubmed: 39014377
doi: 10.1186/s13054-024-05020-z
pii: 10.1186/s13054-024-05020-z
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Observational Study
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
246Subventions
Organisme : NIGMS NIH HHS
ID : R21GM151703
Pays : United States
Organisme : NIGMS NIH HHS
ID : R21GM150093
Pays : United States
Organisme : NIGMS NIH HHS
ID : R21GM150093
Pays : United States
Organisme : NIGMS NIH HHS
ID : R21GM151703
Pays : United States
Organisme : NIGMS NIH HHS
ID : R21GM151703
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01HL149910
Pays : United States
Organisme : National Institute of Child Health and Human Development
ID : R01HD105939
Informations de copyright
© 2024. The Author(s).
Références
Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200–11.
doi: 10.1016/S0140-6736(19)32989-7
pubmed: 31954465
pmcid: 6970225
Global report on the epidemiology and burden of sepsis: current evidence, identifying gaps and future directions. World Health Organization. 2020. p.56. Available from: https://apps.who.int/iris/bitstream/handle/10665/334216/9789240010789-eng.pdf?sequence=1&isAllowed=y
Marshall JC. Why have clinical trials in sepsis failed? Trends Mol Med. 2014;20(4):195–203.
doi: 10.1016/j.molmed.2014.01.007
pubmed: 24581450
Shah FA, Meyer NJ, Angus DC, Awdish R, Azoulay É, Calfee CS, et al. A research agenda for precision medicine in sepsis and acute respiratory distress syndrome: an Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2021;204(8):891–901.
doi: 10.1164/rccm.202108-1908ST
pubmed: 34652268
pmcid: 8534611
Wong HR, Cvijanovich N, Lin R, Allen GL, Thomas NJ, Willson DF, et al. Identification of pediatric septic shock subclasses based on genome-wide expression profiling. BMC Med. 2009;7:34.
doi: 10.1186/1741-7015-7-34
pubmed: 19624809
pmcid: 2720987
Davenport EE, Burnham KL, Radhakrishnan J, Humburg P, Hutton P, Mills TC, et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir Med. 2016;4(4):259–71.
doi: 10.1016/S2213-2600(16)00046-1
pubmed: 26917434
pmcid: 4820667
Scicluna BP, van Vught LA, Zwinderman AH, Wiewel MA, Davenport EE, Burnham KL, et al. Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. Lancet Respir Med. 2017;5(10):816–26.
doi: 10.1016/S2213-2600(17)30294-1
pubmed: 28864056
Sweeney TE, Perumal TM, Henao R, Nichols M, Howrylak JA, Choi AM, et al. A community approach to mortality prediction in sepsis via gene expression analysis. Nat Commun. 2018;9(1):694.
doi: 10.1038/s41467-018-03078-2
pubmed: 29449546
pmcid: 5814463
Yang JO, Zinter MS, Pellegrini M, Wong MY, Gala K, Markovic D, et al. Whole blood transcriptomics identifies subclasses of pediatric septic shock. Crit Care. 2023;27(1):486.
doi: 10.1186/s13054-023-04689-y
pubmed: 38066613
pmcid: 10709863
Wong HR, Cvijanovich N, Lin R, Allen GL, Thomas NJ, Willson DF, et al. Identification of pediatric septic shock subclasses based on genome-wide expression profiling. BMC Med. 2009;7(1):34.
doi: 10.1186/1741-7015-7-34
pubmed: 19624809
pmcid: 2720987
Wong HR, Cvijanovich NZ, Anas N, Allen GL, Thomas NJ, Bigham MT, et al. Developing a clinically feasible personalized medicine approach to pediatric septic shock. Am J Respir Crit Care Med. 2015;191(3):309–15.
doi: 10.1164/rccm.201410-1864OC
pubmed: 25489881
pmcid: 4351580
Antcliffe DB, Burnham KL, Al-Beidh F, Santhakumaran S, Brett SJ, Hinds CJ, et al. Transcriptomic signatures in sepsis and a differential response to steroids. From the VANISH randomized trial. Am J Respir Crit Care Med. 2019;199(8):980–6.
doi: 10.1164/rccm.201807-1419OC
pubmed: 30365341
pmcid: 6467319
Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014;2(8):611–20.
doi: 10.1016/S2213-2600(14)70097-9
pubmed: 24853585
pmcid: 4154544
Calfee CS, Delucchi KL, Sinha P, Matthay MA, Hackett J, Shankar-Hari M, et al. ARDS subphenotypes and differential response to simvastatin: secondary analysis of a randomized controlled trial. Lancet Respir Med. 2018;6(9):691–8.
doi: 10.1016/S2213-2600(18)30177-2
pubmed: 30078618
pmcid: 6201750
Sinha P, Furfaro D, Cummings MJ, Abrams D, Delucchi K, Maddali MV, et al. Latent class analysis reveals COVID-19-related acute respiratory distress syndrome subgroups with differential responses to corticosteroids. Am J Respir Crit Care Med. 2021;204(11):1274–85.
doi: 10.1164/rccm.202105-1302OC
pubmed: 34543591
pmcid: 8786071
Dahmer MK, Yang G, Zhang M, Quasney MW, Sapru A, Weeks HM, et al. Identification of phenotypes in paediatric patients with acute respiratory distress syndrome: a latent class analysis. Lancet Respir Med. 2022;10(3):289–97.
doi: 10.1016/S2213-2600(21)00382-9
pubmed: 34883088
Yehya N, Zinter MS, Thompson JM, Lim MJ, Hanudel MR, Alkhouli MF, et al. Identification of molecular subphenotypes in two cohorts of paediatric ARDS. Thorax. 2023;thorax-2023–220130.
Sinha P, Kerchberger VE, Willmore A, Chambers J, Zhuo H, Abbott J, et al. Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials. Lancet Respir Med. 2023
Wong HR, Caldwell JT, Cvijanovich NZ, Weiss SL, Fitzgerald JC, Bigham MT, et al. Prospective clinical testing and experimental validation of the Pediatric Sepsis Biomarker Risk Model. Sci Transl Med. 2019;11:518.
doi: 10.1126/scitranslmed.aax9000
Atreya MR, Cvijanovich NZ, Fitzgerald JC, Weiss SL, Bigham MT, Jain PN, et al. Integrated PERSEVERE and endothelial biomarker risk model predicts death and persistent MODS in pediatric septic shock: a secondary analysis of a prospective observational study. Crit Care. 2022;26(1):210.
doi: 10.1186/s13054-022-04070-5
pubmed: 35818064
pmcid: 9275255
Atreya MR, Cvijanovich NZ, Fitzgerald JC, Weiss SL, Bigham MT, Jain PN, et al. Prognostic and predictive value of endothelial dysfunction biomarkers in sepsis-associated acute kidney injury: risk-stratified analysis from a prospective observational cohort of pediatric septic shock. Crit Care. 2023;27(1):260.
doi: 10.1186/s13054-023-04554-y
pubmed: 37400882
pmcid: 10318688
Goldstein B, Giroir B, Randolph A, International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(1):2–8.
Bießmann F, Rukat T, Schmidt P, Naidu P, Schelter S, Taptunov A, et al. DataWig: Missing value imputation for tables.
Wong HR, Cvijanovich NZ, Anas N, Allen GL, Thomas NJ, Bigham MT, et al. PERSEVERE-II: Redefining the pediatric sepsis biomarker risk model with septic shock phenotype. Crit Care Med. 2016;44(11):2010–7.
doi: 10.1097/CCM.0000000000001852
pubmed: 27513537
pmcid: 5201138
Fabregat A, Jupe S, Matthews L, Sidiropoulos K, Gillespie M, Garapati P, et al. The reactome pathway knowledgebase. Nucleic Acids Res. 2018;46(D1):D649–55.
doi: 10.1093/nar/gkx1132
pubmed: 29145629
Kwok AJ, Allcock A, Ferreira RC, Cano-Gamez E, Smee M, Burnham KL, et al. Neutrophils and emergency granulopoiesis drive immune suppression and an extreme response endotype during sepsis. Nat Immunol. 2023;24(5):767–79.
doi: 10.1038/s41590-023-01490-5
pubmed: 37095375
Zheng H, Rao AM, Dermadi D, Toh J, Murphy Jones L, Donato M, et al. Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses. Immunity. 2021;54(4):753-768.e5.
doi: 10.1016/j.immuni.2021.03.002
pubmed: 33765435
pmcid: 7988739
Pollack MM, Patel KM, Ruttimann UE. The Pediatric Risk of Mortality III–Acute Physiology Score (PRISM III-APS): a method of assessing physiologic instability for pediatric intensive care unit patients. J Pediatr. 1997;131(4):575–81.
doi: 10.1016/S0022-3476(97)70065-9
pubmed: 9386662
Chesnaye NC, Stel VS, Tripepi G, Dekker FW, Fu EL, Zoccali C, et al. An introduction to inverse probability of treatment weighting in observational research. Clin Kidney J. 2021;15(1):14–20.
doi: 10.1093/ckj/sfab158
pubmed: 35035932
pmcid: 8757413
Bos LD, Schouten LR, van Vught LA, Wiewel MA, Ong DSY, Cremer O, et al. Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis. Thorax. 2017;72(10):876–83.
doi: 10.1136/thoraxjnl-2016-209719
pubmed: 28450529
Bhatraju PK, Zelnick LR, Herting J, Katz R, Mikacenic C, Kosamo S, et al. Identification of acute kidney injury subphenotypes with differing molecular signatures and responses to vasopressin therapy. Am J Respir Crit Care Med. 2019;199(7):863–72.
doi: 10.1164/rccm.201807-1346OC
pubmed: 30334632
pmcid: 6444649
Nadel S, Goldstein B, Williams MD, Dalton H, Peters M, Macias WL, et al. Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial. Lancet. 2007;369(9564):836–43.
doi: 10.1016/S0140-6736(07)60411-5
pubmed: 17350452
Bos LDJ, Scicluna BP, Ong DSY, Cremer O, van der Poll T, Schultz MJ. Understanding heterogeneity in biologic phenotypes of acute respiratory distress syndrome by leukocyte expression profiles. Am J Respir Crit Care Med. 2019;200(1):42–50.
doi: 10.1164/rccm.201809-1808OC
pubmed: 30645145
Neyton LPA, Sinha P, Sarma A, Mick E, Kalantar K, Chen S, et al. Host and microbe blood metagenomics reveals key pathways characterizing critical illness phenotypes. Am J Respir Crit Care Med. 2024
Sinha P, Neyton L, Sarma A, Wu N, Jones C, Zhuo H, et al. Molecular phenotypes of ARDS in the ROSE trial have differential outcomes and gene expression patterns that differ at baseline and longitudinally over time. Am J Respir Crit Care Med. 2024
de Grooth HJ, Cremer OL. Beyond patterns: how to assign biological meaning to ARDS and sepsis phenotypes. Lancet Respir Med. 2023
Sweeney TE, Azad TD, Donato M, Haynes WA, Perumal TM, Henao R, et al. Unsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clusters. Crit Care Med. 2018;46(6):915–25.
doi: 10.1097/CCM.0000000000003084
pubmed: 29537985
pmcid: 5953807
van Amstel RBE, Kennedy JN, Scicluna BP, Bos LDJ, Peters-Sengers H, Butler JM, et al. Uncovering heterogeneity in sepsis: a comparative analysis of subphenotypes. Intensive Care Med. 2023. https://doi.org/10.1007/s00134-023-07239-w .
doi: 10.1007/s00134-023-07239-w
pubmed: 38015264
pmcid: 10622359